Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Blood Screening Market by Technology (Western Blot Assay, Reverse Polymerase Chain Reaction (RPCR), Enzyme-Linked Immunosorbent Assay (ELISA)), By Product Type (Instruments, Software and Services, Reagents & Kits)- Global size Analysis and Industry Forecast, 2018-2023.

 Healthcare and Pharmaceuticals

Report Overview

Global Blood Screening Market was valued at USD 2.35 Billion in the year 2017. Global Blood Screening Market is further estimated to grow at a CAGR of 4.46% from 2018 to 2023. North America region holds the highest market share in 2017 with APAC region is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the biggest market in 2017 and it is projected to grow at a gradual pace in the coming years.

Grifols (Spain), Roche Diagnostics (Switzerland), bioMérieux (France), Abbott Laboratories (U.S.) are some of the key manufacturers in the Global Blood Screening Market with Roche Diagnostics holding the substantial market share because of its better global presence both at production and at an operational level. Rising research and development expenses to cater changing demand of end users, similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.

Drivers

            Boosting Demand for blood supply

            Increased focus on the safety of blood

Restrain

            Lack of regulatory standards

            Level of required financial investment & lack of technical expertise

Opportunity

            Rising importance of diagnostics in improving healthcare quality

            Development of emerging markets for NAT technology.

Challenge

            Supply of safe blood

            Intense competition and reduced healthcare reimbursement

The NAT (Nucleic Acid Test) segment is likely to hold the top market share during the forecast period. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income) to pay for NAT-tested blood.

On the other hand, hospitals & clinical Laboratories for users is expected to grow at the highest CAGR of during the year 2017-2023. Majorly because there is increasing demand for donated blood, growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, increasing number of donations worldwide, and growth in government funding to charitable trusts.

Key Benefits for Stakeholders

Blood screening Manufacturers, Distributors, and Retailers

Research and Consulting organization

Technology Standards Organizations, Forums, Alliances and Associations

End-use industries

Regulatory bodies, policy actors, and consumers.

By Products & Services                                                          

Instruments                  

Software and Services               

Reagents & Kits             

Assays/consumables

By Technology                        

Western Blot Assay                   

Reverse Polymerase Chain Reaction (RPCR)                    

Enzyme-Linked Immunosorbent Assay (ELISA)                

Nucleic Acid Test (NAT)                                                  

Next-Generation Sequencing (NGS)                    

Rapid Tests

By Users                                 

Hospitals                      

Blood Banks

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

1. Abbott Laboratories                

2. Ortho Clinical Diagnostics, Inc.            

3. Biomérieux SA                      

4. Grifols SA                 

5. F. Hoffmann-La Roche AG                   

6. Becton, Dickinson, and Company                     

7. Qiagen Netherlands (includes Digene)             

8. Bio-Rad Laboratories, Inc.                  

9. Agilent Technologies (Dako)               

10. Trinity Biotech 

(A brief overview of another 13 companies is also provided) 

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1. Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2. Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3. To avoid bias, we filter the collected data collected from authenticated sources.
  4. GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5. Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6. Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Blood Screening Market by products & Services                            

6.1 Introduction            

6.2 Instruments            

6.3 Software and Services                     

6.4 Reagents & Kits                   

            6.4.1 ELISA Reagents & Kits       

                        6.4.1.1  Conjugates (Antigen or Antibody-Conjugated Enzyme)

                        6.4.1.2  Sample Diluents and Wash Solutions

                        6.4.1.3  Immunosorbents

                        6.4.1.4  Substrates (Of Enzymes)

                        6.4.1.5  Controls

            6.4.2 NAT Reagents & Kits          

            6.4.3 Other Reagents     

6.5 Assays/consumables

7. Blood Screening Market by Technology                              

7.1 Western Blot Assay              

7.2 Reverse Polymerase Chain Reaction (RPCR)               

7.3 Enzyme-Linked Immunosorbent Assay (ELISA)                       

            7.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Generation   

            7.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Platform       

                        7.3.2.1  Fluorescence Immunoassay (FIA)

                        7.3.2.2  Colorimetric Immunoassay (CI)

                        7.3.2.3  Chemiluminescence Immunoassay (CLIA)

7.4 Nucleic Acid Test (NAT)                    

            7.4.1 Real-Time Polymerase Chain Reaction (PCR)           

            7.4.2 Transcription-Mediated Amplification           

7.5 Next-Generation Sequencing (NGS)               

7.6 Rapid Tests

8. Blood Screening Market by Users                           

8.1 Hospitals                 

8.2 Blood Banks

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. Germany

       9.3.2. France

       9.3.3. U.K.

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. China

       9.4.2. Japan

       9.4.3. India

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America

             9.5.1.1. Brazil

             9.5.1.2. Argentina

             9.5.1.3. Rest of Latin America

       9.5.2. The Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Abbott laboratories             

10.2 Ortho Clinical Diagnostics, Inc.                    

10.3 Biomérieux SA                   

10.4 Grifols SA              

10.5 F. Hoffmann-La Roche AG               

10.6 Becton, Dickinson and Company                  

10.7 Qiagen Netherlands (includes Digene)                      

10.8 Bio-Rad Laboratories, Inc.              

10.9 Agilent Technologies (Dako)            

10.10 Trinity Biotech

(A brief overview of another 13 companies is also provided) 

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

 

List of Tables (97 Tables)

Table 1 Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 2 Global Market, By Volume (Number of Tests), 2017
Table 3 North America: Market, By Volume (Number of Tests), 2017
Table 4 Europe: Market, By Volume (Number of Tests), 2017
Table 5 Asia: Market, By Volume (Number of Tests), 2017
Table 6 Market Size for NAT, By Country, 2017-2023(USD Million)
Table 7 Market Size for NAT, By Type, 2017-2023(USD Million)
Table 8 TMA Market Size, By Country, 2017-2023(USD Million)
Table 9 Real-Time PCR Market Size, By Country, 2017-2023(USD Million)
Table 10 Market Size for ELISA, By Country, 2017-2023(USD Million)
Table 11 Market Size for ELISA, By Platform, 2017-2023(USD Million)
Table 12 CLIA Market Size, By Country, 2017-2023(USD Million)
Table 13 FIA Market Size, By Country, 2017-2023(USD Million)
Table 14 CI Market Size, By Country, 2017-2023(USD Million)
Table 15 Market Size for ELISA, By Generation, 2014-2021 (USD Million)
Table 16 First-Generation ELISA Market Size, By Country, 2017-2023(USD Million)
Table 17 Second-Generation ELISA Market Size, By Country, 2017-2023(USD Million)
Table 18 Third-Generation ELISA Market Size, By Country, 2017-2023(USD Million)
Table 19 Fourth-Generation ELISA Market Size, By Country, 2017-2023(USD Million)
Table 20 Market Size for Rapid Tests, By Country, 2017-2023(USD Million)
Table 21 Market Size for Western Blot Assay, By Country, 2017-2023(USD Million)
Table 22 Market Size for NGS, By Country, 2017-2023(USD Million)
Table 23 Market Size, By Product and Service, 2017-2023(USD Million)
Table 24 Blood Screening Reagents and Kits Market Size, By Country, 2017-2023(USD Million)
Table 25 Blood Screening Reagents and Kits Market Size, By Type, 2017-2023(USD Million)
Table 26 NAT Reagents & Kits Market Size, By Country, 2017-2023(USD Million)
Table 27 NAT Reagents & Kits Market Size, By Type, 2017-2023(USD Million)
Table 28 ELISA Reagents & Kits Market Size, By Country, 2017-2023(USD Million)
Table 29 ELISA Reagents & Kits Market Size, By Type, 2017-2023(USD Million)
Table 30 Other Reagents & Kits Market Size, By Country, 2017-2023(USD Million)
Table 31 Blood Screening Instruments Market Size, By Country, 2017-2023(USD Million)
Table 32 Blood Screening Instruments Market Size, By Purchase Mode, 2017-2023(USD Million)
Table 33 Rental Purchase Market Size, By Country, 2017-2023(USD Million)
Table 34 Outright Purchase Market Size, By Country, 2017-2023(USD Million)
Table 35 Blood Screening Software and Services Market Size, By Country, 2017-2023(USD Million)
Table 36 Market Size, By End User, 2017-2023(USD Million)
Table 37 Market Size for Blood Banks, By Country, 2017-2023(USD Million)
Table 38 Market Size for Hospitals, By Country, 2017-2023(USD Million)
Table 39 Global Market Size, By Region, 2012–2019 (USD Million)
Table 40 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 41 North America: Market Size, By Technology, 2014-2021 (USD Million)
Table 42 North America: Market Size, By Product and Service, 2017-2023(USD Million)
Table 43 North America: Market Size, By End User, 2017-2023(USD Million)
Table 44 Number of Organ Transplantations Performed in the U.S., 2014-2017
Table 45 U.S.: Market Size, By Technology, 2017-2023(USD Million)
Table 46 U.S.: Market Size, By Product and Service, 2017-2023(USD Million)
Table 47 U.S.: Market Size, By End User, 2017-2023(USD Million)
Table 48 Canada: Market Size, By Technology, 2017-2023(USD Million)
Table 49 Canada: Market Size, By Product and Service, 2017-2023(USD Million)
Table 50 Canada: Market Size, By End User, 2017-2023(USD Million)
Table 51 Europe: Market Size, By Country, 2017-2023(USD Million)
Table 52 Europe: Market Size, By Technology, 2017-2023(USD Million)
Table 53 Europe: Market Size, By Product and Service, 2017-2023(USD Million)
Table 54 Europe: Market Size, By End User, 2017-2023(USD Million)
Table 55 Germany: Market Size, By Technology, 2017-2023(USD Million)
Table 56 Germany: Market Size, By Product and Service, 2017-2023(USD Million)
Table 57 Germany: Market Size, By End User, 2017-2023(USD Million)
Table 58 France: Market Size, By Technology, 2017-2023(USD Million)
Table 59 France: Market Size, By Product and Service, 2017-2023(USD Million)
Table 60 France: Market Size, By End User, 2017-2023(USD Million)
Table 61 U.K.: Market Size, By Technology, 2017-2023(USD Million)
Table 62 U.K.: Market Size, By Product and Service, 2017-2023(USD Million)
Table 63 U.K.: Market Size, By End User, 2017-2023(USD Million)
Table 64 Italy: Market Size, By Technology, 2017-2023(USD Million)
Table 65 Italy: Market Size, By Product and Service, 2017-2023(USD Million)
Table 66 Italy: Market Size, By End User, 2017-2023(USD Million)
Table 67 Spain: Market Size, By Technology, 2017-2023(USD Million)
Table 68 Spain: Market Size, By Product and Service, 2017-2023(USD Million)
Table 69 Spain: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 70 RoE: Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 71 RoE: Blood Screening Market Size, By Product and Service, 2017-2023(USD Million)
Table 72 RoE: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 73 Asia: Blood Screening Market Size, By Country, 2017-2023(USD Million)
Table 74 Asia: Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 75 Asia: Blood Screening Market Size, By Product and Service, 2017-2023(USD Million)
Table 76 Asia: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 77 Japan: Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 78 Japan: Blood Screening Market Size, By Product and Service, 2017-2023(USD Million)
Table 79 Japan: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 80 China: Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 81 China: Blood Screening Market Size, By Product and Service, 2017-2023(USD Million)
Table 82 China: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 83 India: Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 84 India: Blood Screening Market Size, By Product and Service, 2017-2023(USD Million)
Table 85 India: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 86 RoA: Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 87 RoA: Blood Screening Market Size, By Product and Service, 2017-2023(USD Million)
Table 88 RoA: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 89 RoW: Blood Screening Market Size, By Technology, 2017-2023(USD Million)
Table 90 RoW: Blood Screening Market Size, By Product and Service, 2017-2023(USD Million)
Table 91 RoW: Blood Screening Market Size, By End User, 2017-2023(USD Million)
Table 92 Product Launches, 2013-2016
Table 93 Regulatory Approvals, 2017-2023
Table 94 Agreements, 2017-2023
Table 95 Partnerships, 2017-2023
Table 96 Acquisitions, 2017-2023
Table 97 Expansions, 2017-2023


List of Figures (30 Figures)

Figure 1 Research Design
Figure 2 Blood Screening Market: Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Blood Screening Market Size, By Product and Service, 2016 vs 2021 (USD Billion)
Figure 6 Blood Screening Market Size, By Technology, 2016 vs 2021 (USD Billion)
Figure 7 Blood Screening Market Size, By End User, 2016 vs 2021 (USD Billion)
Figure 8 North America Accounted for the Highest Share of the Blood Screening Market in 2016
Figure 9 Blood Screening Market to Showcase Lucrative Growth Opportunities in the Forecast Period
Figure 10 NAT Segment to Account for the Largest Market Share in 2016
Figure 11 Asia to Grow at the Highest Rate During the Forecast Period
Figure 12 Global Incidences of Cancer
Figure 13 NAT Testing Will Continue to Dominate the Market During the Forecast Period
Figure 14 Reagents & Kits Segment to Hold Largest Share of the Market During the Forecast Period
Figure 15 Blood Banks Segment Will Continue to Dominate the Blood Screening Market During the Forecast Period
Figure 16 Emerging Markets Offer Significant Growth Opportunities
Figure 17 Asian Blood Screening Market Expected to Grow at the Highest CAGR During the Forecast Period
Figure 18 North America: Market Snapshot
Figure 19 Reagents and Kits Segment to Hold Largest Share in the U.S. Market
Figure 20 Europe: Market Snapshot
Figure 21 Germany: Blood Screening Market, By Product and Service
Figure 22 Asia: Blood Screening Market Snapshot
Figure 23 ELISA Segment to Grow at the Highest CAGR in the Japanese Market During 2016–2021
Figure 24 Blood Banks End-User Segment Will Continue to Dominate the Indian Blood Screening Market Till 2021
Figure 25 RoW: Market Snapshot
Figure 26 Product Launches, the Key Strategy Adopted By Leading Players
Figure 27 NAT Blood Screening Market Share Analysis, By Key Player, 2017
Figure 28 Blood Screening Market Share Analysis, By Key Player, 2017
Figure 29 Battle for Market Share: Product Launches, Partnerships and Agreements, the Key Growth Strategies Adopted Between 2014 & 2017
Figure 30 Product Benchmarking of the Top 5 Players

 

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports